Qualmed Health Sciences Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
- Paid Up Capital ₹ 4.74 Cr
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -84.67%
- Profit Growth -70.08%
- Ebitda -112.48%
- Net Worth 0.15%
- Total Assets 8.31%
About Qualmed Health Sciences
Qualmed Health Sciences Limited (QHSL) is a Public Limited Indian Non-Government Company incorporated in India on 24 July 2020 (Four years and six months 11 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 4.74 Cr, as per Ministry of Corporate Affairs (MCA) records.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231TG2020PLC142146
-
Company No.
142146
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
24 Jul 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Qualmed Health Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parikshit Linga
|
Director | 24-Jul-2020 | Current |
|
Mohan Thodupunuri
|
Director | 24-Jul-2020 | Current |
| Bhargava Linga | Additional Director | 18-Jun-2024 | Current |
Financial Performance of Qualmed Health Sciences.
Qualmed Health Sciences Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 84.67% decrease. The company also saw a substantial fall in profitability, with a 70.08% decrease in profit. The company's net worth moved up by a moderate rise of 0.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Qualmed Health Sciences?
In 2023, Qualmed Health Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Vuesol Software Solutions Private LimitedBhargava Linga is a mutual person
-
Amar Real LimitedParikshit Linga is a mutual person
-
Simply Better Nutrition Private Limited
Parikshit Linga and Mohan Thodupunuri are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Qualmed Health Sciences?
Qualmed Health Sciences has a workforce of 0 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Qualmed Health Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Qualmed Health Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
